ISI Promotes Adam Sherlock to Managing Director, Europe
-
Sherlock brings 20 years of International Pharmaceutical experience
to position
-
Succeeds Retiring Managing Director Gilbert Kampfner
ESCHBORN, Germany & WHIPPANY, N.J. (Business Wire EON/PRWEB ) August 20, 2008 --
Image Solutions Inc. (ISI),
a leading provider of software and services for the life sciences
industry, today named Adam Sherlock to the position of Managing
Director, Europe, effective immediately. Sherlock replaces Gilbert
Kampfner, who is retiring after almost nine years with the company.
“It is a bittersweet day for the ISI family,”
said Jinsoo Kim, founder and chief executive officer of ISI. “Gil
Kampfner’s leadership will be missed, but our
ability to replace him with an industry veteran like Adam Sherlock is a
testament to our team building and succession planning.”
Sherlock, who joined ISI as Director of Business Development last year,
has spent 20 years in the IT industry, specifically life sciences
companies. As chief operating officer of IQ Consultancy, a provider of
change management services to the pharmaceutical industry, Sherlock’s
extensive business management experience was instrumental in securing
the company’s successful acquisition by a
major Swedish IT consultancy firm. Prior to IQ Consultancy, Sherlock was
founder and managing director of the Synapse Partnership, a company
specializing in regulatory software for the life sciences market.
Sherlock also served as director of business development at major
medical communications agency Gardiner-Caldwell Communications, which
grew revenue 400 percent over his five-year tenure.
Kampfner retires after 35 years in the drug development industry. His
career has spanned the entire history of modern clinical trials and data
management, and has included building a European business for ISI with
clients such as pharmaceutical industry giants AstraZeneca, Boehringer
Ingelheim, and Sanofi Aventis.
Under Sherlock’s leadership, ISI will continue
to aggressively grow its regulatory consulting practice, outsourcing
services, and European market share of its flagship submission products
eCTDXPress and ISIPublisher. Earlier this year, ISI announced that it
integrated its product suite to provide European companies with the
flexibility to submit to regulatory agencies in any format –
paper, electronic Common Technical Document (eCTD) or non-eCTD
electronic submissions.
About Image Solutions
Founded in 1992, Image Solutions, Inc (ISI) is a proven market leader in
providing submissions solutions, process services and consulting to Life
Sciences companies as a way to improve clinical and regulatory processes
that bring new medicines to market. ISI was among the first professional
services firm to deliver electronic submissions to the industry and
since has delivered more than 1,600 electronic submissions and 900 eCTD
submissions. The company has a 48 percent market share among Top 50
global pharmaceutical for its flagship submission product, eCTDXPress,
and 4 of the top 10 pharma now have ISIPublisher.
ISI is a privately held company with headquarters in Whippany, New
Jersey and operations throughout the U.S., Europe and Asia. ISI also
remains committed to giving back to society and sharing its success with
others by donating 10 percent of annual net profits to over 20
recognized charitable organisations. For more information, visit the
company website at www.imagesolutions.com.
Tags: eCTD; regulatory submission publishing; electronic
submissions; drug development; drug development technology;
pharmaceutical industry; biotechnology; European pharmaceutical;
European life sciences
Suggested Links: ISI Web
site; FDA
eCTD Guidance
Image Solutions, Inc., ISIToolBox,ISIRender, Virtual Link Manager,
eCTDXPress, ISIPublisher and ISIRegTracker are trademarks or registered
trademarks of Image Solutions, Inc. which may be registered in the
United States and internationally. Other brand names may be trademarks
or registered trademarks of others
See the original story at: http://eon.businesswire.com/releases/sherlock/director/prweb1232014.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1UaGlyLVN1bW0tU3VtbS1Db3VwLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
